Target-Mediated Drug Disposition Model for Bispecific Antibodies : Properties, Approximation and Optimal Dosing Strategy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: CPT : pharmacometrics & systems pharmacology ; 8 (2019), 3. - S. 177-187. - ISSN 2163-8306. - eISSN 2163-8306
- Ereignis
-
Veröffentlichung
- (wo)
-
Konstanz
- (wer)
-
KOPS Universität Konstanz
- (wann)
-
2019
- Urheber
-
Schropp, Johannes
Khot, Antari
Shah, Dhaval K.
Koch, Gilbert
- URN
-
urn:nbn:de:bsz:352-2-18d9ppizcr8nf1
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:53 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schropp, Johannes
- Khot, Antari
- Shah, Dhaval K.
- Koch, Gilbert
- KOPS Universität Konstanz
Entstanden
- 2019
Ähnliche Objekte (12)
Intein mediated high throughput screening for bispecific antibodies
Intein mediated high throughput screening for bispecific antibodies
Arming Antibodies for Cancer Therapy: Transglutaminase-Mediated Toxin Conjugation
Discrete NURBS-Surface Approximation using an Evolutionary Strategy
The role of antibodies against endothelial cells in immune mediated thrombocytopenia
The role of antibodies against endothelial cells in immune mediated thrombocytopenia
Proteolytic Antibodies – Myth or Reality? Attempts to isolate proteolytic antibodies via Proteolytic Antigen Cleavage-Mediated AmplificatioN (PACMAN)
Monoclonal antibodies reacting with Schistosoma japonicum eggs and their target epitopes
Towards novel targets for receptor-mediated nanoparticle delivery
Anti-Fc[alpha]RI monoclonal antibodies resolve IgA autoantibody-mediated disease
Discovery of novel therapeutic antibodies and targets using tumor-infiltrating B cells
Modulation of γδ T-cell mediated cytotoxicity by checkpiont inhibition and integrin antibodies
Intein mediated high throughput screening for bispecific antibodies
Intein mediated high throughput screening for bispecific antibodies
Arming Antibodies for Cancer Therapy: Transglutaminase-Mediated Toxin Conjugation
Discrete NURBS-Surface Approximation using an Evolutionary Strategy
The role of antibodies against endothelial cells in immune mediated thrombocytopenia
The role of antibodies against endothelial cells in immune mediated thrombocytopenia
Proteolytic Antibodies – Myth or Reality? Attempts to isolate proteolytic antibodies via Proteolytic Antigen Cleavage-Mediated AmplificatioN (PACMAN)
Monoclonal antibodies reacting with Schistosoma japonicum eggs and their target epitopes
Towards novel targets for receptor-mediated nanoparticle delivery
Anti-Fc[alpha]RI monoclonal antibodies resolve IgA autoantibody-mediated disease
Discovery of novel therapeutic antibodies and targets using tumor-infiltrating B cells
Modulation of γδ T-cell mediated cytotoxicity by checkpiont inhibition and integrin antibodies
Intein mediated high throughput screening for bispecific antibodies
Intein mediated high throughput screening for bispecific antibodies
Arming Antibodies for Cancer Therapy: Transglutaminase-Mediated Toxin Conjugation
Discrete NURBS-Surface Approximation using an Evolutionary Strategy
The role of antibodies against endothelial cells in immune mediated thrombocytopenia
The role of antibodies against endothelial cells in immune mediated thrombocytopenia
Proteolytic Antibodies – Myth or Reality? Attempts to isolate proteolytic antibodies via Proteolytic Antigen Cleavage-Mediated AmplificatioN (PACMAN)
Monoclonal antibodies reacting with Schistosoma japonicum eggs and their target epitopes
Towards novel targets for receptor-mediated nanoparticle delivery
Anti-Fc[alpha]RI monoclonal antibodies resolve IgA autoantibody-mediated disease
Discovery of novel therapeutic antibodies and targets using tumor-infiltrating B cells